Quikhale Fb 6/400 MCG Rotacaps 30

In the respiratory combination pharmaceutical Quikhale FB 200 Rotacaps 30's belongs to the class of medications that are used to treat the symptoms of asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic (long-term) respiratory disorder in which the airways narrow, swell, and generate excessive mucus, resulting in difficulty breathing. Asthma can be treated with medications. Emphysema (shortness of breath), chronic bronchitis, and other lung illnesses are all part of the COPD group (inflammation of the lining of bronchial tubes). Budesonide (corticosteroid) and Formoterol (an anti-inflammatory medicine) are included in Quikhale FB 200 Rotacaps 30's, which is a combination of two medications (LABA - long-acting beta-agonists or bronchodilator). In the corticosteroid class of medications, budesonide works by reducing irritation and swelling by acting inside the nasal passage and airway lining cells, and it also works by inhibiting the release of certain chemicals that cause inflammatory reactions and allergies. Budesonide is used to treat allergies and inflammatory reactions. Consequently, it provides relief from symptoms such as sneezing, runny or blocked nose, and sinus pain. Formoterol, on the other hand, is a long-acting beta-agonist (also known as a bronchodilator) that relaxes and widens the muscles of the respiratory airways, making it simpler for patients with asthma and COPD to breathe comfortably.